DNA-intercalating antiphage molecules trigger abortive infection through mutual destruction and synergize with bacterial immunity.

Ernst, Larissa; Gätgens, Cornelia; Rackow, Bente; Pozhydaieva, Nadiia; Gaaloul, Elyès; Krüger, Aileen; Seiffarth, Johannes; Bund, Michelle et al. · Proc Natl Acad Sci U S A · 2026

basic_science · Level V

Where this comes from

Abstract

Bacteria deploy diverse antiphage defense systems, including small bioactive molecules providing protection at the multicellular level. DNA-intercalating anthracyclines, such as daunorubicin, exhibit broad antiphage activity, but the underlying mechanism has remained elusive. Here, we systematically screened the <i><i>Escherichia coli</i></i> BASEL phage collection to elucidate the mode of action of DNA-intercalating antiphage molecules. We identified taxonomically distinct clusters of susceptible viral groups and show that for the <i>Tequintavirus</i> Bas33 (<i>Markadamsvirinae</i>), daunorubicin blocks infection after first-step transfer. In the presence of daunorubicin, continued expression of pre-early genes leads to abortive infection via "mutual destruction," where both phage and host succumb. Analogous abortive-infection phenotypes occur across taxonomically diverse phages exposed to chemically distinct DNA-intercalating molecules. Notably, we show that daunorubicin synergizes with downstream nucleic acid-targeting defenses underscoring context-dependent outcomes. Together, these findings reveal how chemical defense contributes to the multilayered antiviral immunity and highlight the intricate interplay between mechanistic inhibition and infection outcome.